Dispatch Bio

@DispatchBio

On a mission to help create a world where all cancer patients can be cured

Philadelphia, PA

Joined May 2024

Following

Followers

Replies Reposts Media

Dispatch Bio
@DispatchBio
Sep 3
Dispatch Bio dosed the first patient in our first clinical trial, now covered by @PhillyInquirer. The piece dives into our first-in-class Flare platform and the science behind our approach to solid tumors, with commentary from our CPO and CMO. Read more:
Dispatch Bio launches its first clinical trial to develop a universal treatment for solid cancers
From inquirer.com
Dispatch Bio
@DispatchBio
Aug 13
Solid tumors have been challenging to treat with immunotherapy due to limitations that DISP-10 is designed to overcome. DV-10 aims to mark tumor cells for CAR T, then replicate to infect cancer cells, creating a feedback loop designed to work across all solid tumor types.
00:00
1
Dispatch Bio
@DispatchBio
Aug 6
Today, we announced the first patient has been dosed in the Ph1 trial of DISP-10, which has received Fast Track designation from the U.S. FDA. DISP-10 is a novel, investigational therapy designed to address key challenges in treating solid tumors. dispatchbio.com/news/first-pat…
Dispatch Bio
@DispatchBio
Jul 30
GI cancers remain among the toughest to treat, with limited options beyond chemo for advanced disease. DISP-10 combines DV-10, a tumor-specific virus, with a BCMA-directed CAR T therapy, for a new #immunotherapy approach.
Dispatch Bio
@DispatchBio
Jul 22
Our co-founder & CPO phoned into @LifeSciencesPA’s podcast: Being a Life Sciences Leader. The conversation covers our story , approach to immunotherapy, what it means to be named Emerging Company of the Year by LSPA & more. Dial in: lifesciencespa.org/being-a-life-s…
00:00